Accurate Testing for Vaginitis
Vaginitis is the leading reason for OBGYN visits1-2
Most women will experience an episode of vaginitis at least once in their lifetime.3 90% of vaginitis is caused by bacterial vaginosis (BV), yeast infection (CV) and trichomonas vaginalis (TV) infections, either individually or in combination; resulting in approximately 10 million OB/GYN visits each year.4-5

NAAT results in more accurate diagnosis and better clinical management
The Aptima® BV and Aptima® CV/TV assays are NAAT tests that identify bacterial vaginosis (BV), vulvovaginal candidiasis (Candida vaginitis or CV) and Trichomoniasis (Trichomonas vaginalis or TV) in symptomatic women from one vaginal sample. NAAT detects 3x more mixed infections cases than clinical diagnosis with wet mount and Amsel’s criteria.9
The Aptima® BV and Aptima® CV/TV assays are NAAT tests that identify bacterial vaginosis (BV), vulvovaginal candidiasis (candida vaginitis or CV) and Trichomoniasis (trichomonas vaginalis or TV) in symptomatic women from one vaginal sample. NAAT detects 3x more mixed infections cases than clinical diagnosis with wet mount and
Amsel’s criteria.9
NAAT detects:
- 3X more Candidiasis + BV mixed infections
- 3X more Candidiasis + TV mixed infections
- 4X more BV + TV mixed infections
Association Between Vaginitis and STIs10
~1 in 5 (18.5%) women who presented with symptoms of vaginitis had a least 1 STI.
“…we found high rates for STIs in women seeking care for symptoms of vaginitis and bacterial vaginosis…”
– Schwebke et al, 202410
STI Prevalence10
BV-positive women had a 2x higher STI infection rate compared to BV-negative women.
STI Prevalence in Women with NAAT BV Diagnosis10
TV and M. gen are significantly associated with BV.
- TV affected nearly 11% of women with BV; M. gen was present in over 9% of women with BV.
Chlamydia (CT) and Gonorrhea (NG) are less common than M. gen and TV in women with BV.
- Women should still be tested for CT and NG as these are serious STIs that can cause significant health problems if left untreated.
Hologic’s offerings
Our suite of testing tools leads the market in accuracy and sensitivity, providing the insights you need for your patient’s best care.11